Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist

Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure maximal efficacy with minimal complication rates.Aim. To study the international normalized ratio (INR) values in patients on VKAs in selected area, find out which patient characteristics that is associate...

Full description

Bibliographic Details
Main Authors:	S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2020-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	vitamin k antagonists international normalized ratio coagulation
Online Access:	https://www.rpcardio.com/jour/article/view/2249

Similar Items

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
by: Inki Moon, et al.
Published: (2019-10-01)

The international normalized ratio (INR) as seen in a population of patients with atrial fibrillation and cerebral infarction undergoing long-term treatment with vitamin K antagonists
by: Szczepańska-Szerej Anna, et al.
Published: (2015-12-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
by: Kuang-Tsu Yang, et al.
Published: (2021-12-01)

Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
by: Aleix Cases, et al.
Published: (2021-09-01)

Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy
by: Shin-Yi Lin, et al.
Published: (2020-12-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective
by: Pierre Levy, et al.
Published: (2019-01-01)

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
by: Shujuan Zhao, et al.
Published: (2020-08-01)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)

Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
by: Giovanni Luca Botto, et al.
Published: (2021-06-01)

Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
by: Foody JM
Published: (2017-01-01)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
by: Maria Cristina Vedovati, et al.
Published: (2019-04-01)

Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)
by: M. Rosa Dalmau Llorca, et al.
Published: (2021-05-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)

Vitamine K
by: Bal dit Sollier Claire, et al.
Published: (2011-03-01)

Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation
by: Zsuzsa Bagoly, et al.
Published: (2020-09-01)

Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01)

Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
by: Xiaojuan Wu, et al.
Published: (2021-07-01)

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
by: Tsuyoshi Shiga, MD, et al.
Published: (2015-12-01)

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Kang-Ling Wang, et al.
Published: (2017-08-01)

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
by: Turagam MK, et al.
Published: (2015-09-01)

Oral Anticoagulants Preference in Hospitalized Patients with Acute Deep Vein Thrombosis or Non-Valvular Atrial Fibrillation
by: Ştefan Cristian Vesa, et al.
Published: (2020-10-01)

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
by: Andrea Rubboli
Published: (2013-12-01)

Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta‐analysis
by: Pradyumna Agasthi, et al.
Published: (2020-04-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type
by: Ceren Eyileten, et al.
Published: (2020-04-01)

Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy
by: Francesco Mennini, et al.
Published: (2012-09-01)

A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation
by: Ling-Yun Zhou, et al.
Published: (2018-11-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registers
by: Venkatesh Kumar Gurusamy, et al.
Published: (2019-02-01)

Real-practice thromboprophylaxis in atrial fibrillation
by: Deambrosis Paola, et al.
Published: (2017-06-01)

Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Mohammed A Kubas, et al.
Published: (2020-01-01)

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
by: Chern-En Chiang, et al.
Published: (2016-11-01)

Single low-dose of apixaban in patients with atrial fibrillation after transcatheter aortic valve implantation
by: Gabriela Veiga-Fernández, et al.
Published: (2020-08-01)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study
by: Sadık Volkan Emren, et al.
Published: (2018-05-01)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
by: Maria Brinkmeier-Theofanopoulou, et al.
Published: (2018-04-01)

Oral Anticoagulant Adequacy in Non-Valvular Atrial Fibrillation in Primary Care: A Cross-Sectional Study Using Real-World Data (Fantas-TIC Study)
by: M. Rosa Dalmau Llorca, et al.
Published: (2021-02-01)